Search results
Snap-on Climbs 10.5% in 3 Months as Growth Faces New Valuation Risks
Snap-on Incorporated SNA has drawn renewed investor interest after a three-month advance, supported by improving operating momentum across several businesses. The latest quarter paired organic sales
Is Snap-on Stock a Buy as Strong Margins Meet a Premium Valuation?
Snap-on Incorporated SNA pairs resilient operations and strong cash generation with a valuation near the top of its five-year range. Second-quarter sales and earnings advanced, while gross margin
Ramaco Resources Q2 Earnings Call Highlights
Key Points
- Interested in Ramaco Resources, Inc.? Here are five stocks we like better.
- Second-quarter performance weakened: Adjusted EBITDA fell to $6 million from $9 million year over year as
INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease
Inspire Medical Systems, Inc. INSP raised its 2026 outlook after second-quarter results exceeded expectations. Better cost control, a richer mix of Inspire V implants and stronger cash generation
Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?
Inspire Medical Systems, Inc. INSP offers investors a difficult trade-off. Its underpenetrated obstructive sleep apnea market, improving margins and financial flexibility support the long-term case.
Inuvo, Shopify: High-Quality Plays on Internet Services
DOC Q2 FFO Beat Estimates on Leasing & Senior Housing Gains
Healthpeak Properties, Inc. DOC reported second-quarter 2026 funds from operations (FFO), as adjusted, of 46 cents per share, which topped the Zacks Consensus Estimate of 44 cents by 4.6%. The
STRL Plunges 19.7% in a Month as Growth Meets Rising Execution Risks
Sterling Infrastructure, Inc. STRL shares have lost 19.7% in the past month, raising the question of whether the retreat offers a better entry point or signals risks that could linger.The pullback
Sterling Raises 2026 Outlook as Backlog Tops $5.6 Billion After Q2
Sterling Infrastructure, Inc. STRL raised its 2026 outlook after second-quarter revenues increased 90% and adjusted earnings more than doubled. The update tests whether rapid expansion in
Can Segment Strength Offset Headwinds for BD Stock Before Q3 Earnings?
Becton Dickinson and Company BDX, popularly known as BD, is scheduled to report third-quarter fiscal 2026 results on Aug. 6, before market open.
In the last reported quarter, the company’s adjusted
Royalty Pharma Q2 Earnings Call Highlights
Key Points
- Interested in Royalty Pharma PLC? Here are five stocks we like better.
- Royalty Pharma raised its 2026 outlook for the second consecutive quarter, now forecasting portfolio receipts
Macerich's Q2 FFO & Revenues Beat Estimates on Strong Portfolio NOI
The Macerich Company MAC reported second-quarter 2026 funds from operations as adjusted (FFOA) of 35 cents per share, up 2.9% year over year and beating the Zacks Consensus Estimate by 6.06%. Total
American Financial Group Q2 Earnings Call Highlights
Key Points
Error: Response status code does not indicate success: 500 (Internal Server Error).American Financial Group (NYSE:AFG) reported
Adient Q3 Earnings Call Highlights
Key Points
- Interested in Adient? Here are five stocks we like better.
- Q3 revenue rose 5% to approximately $3.9 billion, but adjusted EBITDA remained flat at $225 million as Middle East-related
United Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in United Therapeutics Corporation? Here are five stocks we like better.
- Second-quarter revenue was approximately $783 million, essentially flat sequentially, as
Chemours Q2 Earnings Call Highlights
Key Points
- Interested in The Chemours Company? Here are five stocks we like better.
- Second-quarter performance exceeded profit expectations despite sales falling slightly short, as pricing
On Holding (ONON) Ascends While Market Falls: Some Facts to Note
In the latest trading session, On Holding (ONON) closed at $38.19, marking a +1.54% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 0.17%. Meanwhile
TJX (TJX) Gains As Market Dips: What You Should Know
TJX (TJX) ended the recent trading session at $159.92, demonstrating a +1.5% change from the preceding day's closing price. This change outpaced the S&P 500's 0.17% loss on the day. At the same
ADMA Biologics Q2 Earnings Call Highlights
Key Points
- Interested in ADMA Biologics Inc? Here are five stocks we like better.
- Second-quarter revenue rose 2% to $124.4 million, driven by a 24% increase in ASCENIV sales to $102.9 million
Autodesk (ADSK) Gains As Market Dips: What You Should Know
In the latest close session, Autodesk (ADSK) was up +1.19% at $240.03. This move outpaced the S&P 500's daily loss of 0.17%. Meanwhile, the Dow experienced a rise of 0.49%, and the